Soluble flagellin coimmunization attenuates Th1 priming to Salmonella and clearance by modulating dendritic cell activation and cytokine production by Flores-langarica, Adriana et al.
 
 
University of Birmingham
Soluble flagellin coimmunization attenuates Th1
priming to Salmonella and clearance by modulating
dendritic cell activation and cytokine production
Flores-langarica, Adriana; Bobat, Saeeda; Marshall, Jennifer L.; Yam-puc, Juan Carlos;
Cook, Charlotte N.; Serre, Karine; Kingsley, Robert A.; Flores-romo, Leopoldo; Uematsu,
Satoshi; Akira, Shizuo; Henderson, Ian R.; Toellner, Kai M.; Cunningham, Adam F.
DOI:
10.1002/eji.201545564
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Flores-langarica, A, Bobat, S, Marshall, JL, Yam-puc, JC, Cook, CN, Serre, K, Kingsley, RA, Flores-romo, L,
Uematsu, S, Akira, S, Henderson, IR, Toellner, KM & Cunningham, AF 2015, 'Soluble flagellin coimmunization
attenuates Th1 priming to Salmonella and clearance by modulating dendritic cell activation and cytokine
production', European Journal of Immunology, vol. 45, no. 8, pp. 2299-2311.
https://doi.org/10.1002/eji.201545564
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Eligibility for repository : checked 13/11/2015
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Eur. J. Immunol. 2015. 45: 2299–2311 Immunity to infectionDOI: 10.1002/eji.201545564 2299
Soluble flagellin coimmunization attenuates Th1
priming to Salmonella and clearance by modulating
dendritic cell activation and cytokine production
Adriana Flores-Langarica1, Saeeda Bobat1, Jennifer L. Marshall1,
Juan Carlos Yam-Puc2, Charlotte N. Cook1, Karine Serre3,
Robert A. Kingsley4, Leopoldo Flores-Romo2, Satoshi Uematsu5,
Shizuo Akira6,7, Ian R. Henderson1, Kai M. Toellner1
and Adam F. Cunningham1
1 Division of Immunity and Infection, Institute of Biomedical Research, University of
Birmingham, Birmingham, UK
2 Deparamento de Biologia Celular. CINVESTAV. Mexico, D.F. Mexico
3 Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon,
Portugal
4 The Institute of Food Research, Norwich Research Park, Norwich, UK
5 International Research and Development Centre for Mucosal Vaccine, Institute for Medical
Science, The University of Tokyo, Tokyo, Japan
6 Laboratory of Host Defense, World Premier International Immunology Frontier Research
Center, Osaka University, Suita Osaka, Japan
7 Department of Host Defense, Research Institute for Microbial Diseases, Osaka University,
Suita Osaka, Japan
Soluble flagellin (sFliC) from Salmonella Typhimurium (STm) can induce a Th2 response
to itself and coadministered antigens through ligation of TLR5. These properties suggest
that sFliC could potentially modulate responses to Th1 antigens like live STm if both
antigens are given concurrently. After coimmunization of mice with sFliC and STm there
was a reduction in Th1 T cells (T-bet+IFN-γ+ CD4 T cells) compared to STm alone and
there was impaired clearance of STm. In contrast, there was no significant defect in the
early extrafollicular B-cell response to STm. These effects are dependent upon TLR5 and
flagellin expression by STm. Themechanism for these effects is not related to IL-4 induced
to sFliC but rather to the effects of sFliC coimmunization on DCs. After coimmunization
with STm and sFliC, splenic DCs had a lower expression of costimulatory molecules and
profoundly altered kinetics of IL-12 and TNFα expression. Ex vivo experiments using in
vivo conditioned DCs confirmed the effects of sFliC were due to altered DC function during
a critical window in the coordinated interplay between DCs and naı¨ve T cells. This has
marked implications for understanding how limits in Th1 priming can be achieved during
infection-induced, Th1-mediated inflammation.
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Introduction
DCs can efficiently capture, process, and present antigen to T cells
in the T zones of secondary lymphoid tissues such as the spleen. If
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cognate interactions between these two cell types results in T-cell
priming, then cells can differentiate to become Th cells [1]. In vivo,
the direction of Th-cell differentiation is influenced by the nature
of the antigen. Thus, Th1 responses are induced by intracellular
bacteria such as Salmonella enterica serovar Typhimurium (STm),
Th17 responses are characteristic of pneumococcal infection and
Th2 responses are observed after exposure to antigens such as
helminths and alum-precipitated proteins such as OVA. Regulating
the direction and magnitude of the Th response is important since
inappropriate responses are associated with a failure to control
infection or enhanced pathology and inflammation [2, 3]. For
instance, T-bet-deficientmice generate T-cell responses to STmbut
fail to clear the bacteria due to an impairment in Th1 development
[2, 4–7].
To understand how the extent of the Th response is regulated
it is necessary to appreciate the factors that drive the Th response
down one pathway or another. One important element is the envi-
ronment in which the antigen is encountered by the immune
system [4, 8]. Thus, OVA-specific OT-II CD4 T cells responding
to alum-precipitated OVA polarize to Th2, but when the same
antigen is expressed within an attenuated strain of STm then a
Th1 response is generated [4, 9]. In addition, infectious history
can selectively influence the T-cell response. For instance, during
coinfection with STm and the helminth Nippostrongylus brasilien-
sis there is a diminished Th2 response to the helminth, whereas the
Th1 response to STm remains largely unaffected [10]. One possi-
ble interpretation of this is that Th1 responses are more resistant
to modulation than other types of responses.
To better understand the principles behind the regulation of
Th-cell responses some groups, including ourselves, have com-
pared the T-cell response induced to the same antigen when given
in purified form or in its native context as part of a live bac-
terium. One molecule that is helpful for this is flagellin, which is
the component antigen of the flagellar filament [11]. This protein
is exposed on the bacterial surface, so it is available to B cells,
can be expressed at high levels and is a significant target of the
T-cell response to STm [12]. Furthermore, when administered in
purified form, soluble flagellin (sFliC), from STm has the valuable
property of having auto-adjuvant activity through its ligation of
TLR5 and other mechanisms [13–15]. Therefore responses to this
protein can be assessed in the absence of potentially biasing influ-
ences such as exogenous adjuvant. Previous studies have shown
that in the spleen the sFliC-specific response is Th1 when it is
encountered in its native context as part of STm, with a robust
induction of T-bet and type-specific cytokine IFN-γ. In contrast,
after immunization with sFliC there is a clear induction of Th2
features such as GATA-3 mRNA and IL-4 protein. The dichotomy
of the T-cell response is also reflected in the B-cell response to
sFliC, with the direction of IgG switching to live bacteria primarily
to a Th1-reflecting IgG2a, whereas to sFliC it is a Th2-reflecting
IgG1 [4, 16].
Since the response to the same antigen can differ depending
upon the context in which it is encountered, it suggested to us
that DCs were important, since they are at the center of direct-
ing Th differentiation [17]. Previously, our studies have shown
a major role for monocyte-derived DCs (moDCs) in Th1 prim-
ing through their capacity to collaborate with conventional DCs
(cDCs) [18]. This shows that factors influencing the biology of
DCs have a corresponding effect on their capacity to prime Th
responses. Therefore we asked what the consequence for the host
T-cell response to STm would be after coadministration of live
STm and sFliC. These studies showed that the presence of sFliC
reduced the numbers of Th1 cells after STm compared to STm
alone via its TLR5-dependent effects on DCs. Therefore, sFliC can
modify the response to STm through modulating DC function.
Results
Mice coimmunized with STm and sFliC have lower
IFN-γ T-cell responses
We have previously shown that sFliC induces a Th2-dominated
response characterized by a marked induction of IL-4 and GATA-3
mRNA expression in antigen-specific T cells, but not IFN-γ [4, 19].
In contrast, when FliC is encountered as part of STm a Th1
response is induced, characterized by IFN-γ and T-bet expression.
This led us to examine if there was any modulation of the response
if the immune system encountered both antigens simultaneously.
To do this, SM1 transgenic T cells (specific for a peptide in STm
flagellin) were used to generate chimeras that were then immu-
nized with PBS, STm, sFliC, or STm and sFliC. As expected and
shown in Fig. 1A, sFliC induced little IFN-γ in SM1 T cells while
STm induced a robust IFN-γ response [4]. However, in mice that
received both antigens there was a reduction in the proportion
and number of IFN-γ-producing SM1 T cells in comparison with
the STm only infected group. In contrast, IL-4 production was
readily detected in sFliC-immunized mice by ELISPOT, but not in
the other groups. This included mice that received STm and sFliC
together (Fig. 1A and [4]).
To test whether sFliC and STm coimmunization could similarly
impact the endogenous CD4 T-cell (gating strategy shown in Sup-
porting Information Fig. 1A) response, WT mice were immunized
with STm, sFliC, or both. After 7 days a diminution of the IFN-γ
response was observed in the mice coimmunized with STm and
sFliC as seen in the transgenic SM1 system. This response was not
only observed in anti-CD3 restimulated cultures but also after res-
timulation of antigen-specific T cells with purified STmoutermem-
brane proteins (OMPS) (Fig. 1B). IL-4 was detected in the sFliC
primed mice in the absence of transgenic T cells. These changes in
cytokine responses were not due to fewer activated T cells since
the proportion and the absolute numbers of CD62LloCD44+ CD4
T cells were similar at day 7 in both groups that received STm
(Fig. 1C). We tested if this modulation of the T-cell response was
associated with an altered frequency or number of Treg cells or if
the effect was IL-10 mediated. At day 7 postimmunization, when
we observed the diminution of IFN-γ expression by T cells there
was no difference in the numbers of Treg cells between the mice
immunized with STm or STm/sFliC (Supporting Information Fig.
2A), nor was there a difference between WT and IL-10-deficient
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 1. sFliC coimmunization with STm influences the T-cell IFN-γ response. (A) SM1 splenocytes were adoptively transferred into TCRβδ−/−
mice; 24 h posttransfer (A) chimeras and (B) WT mice were immunized with PBS (white) or 5 × 105 STm (black), 20 μg sFliC (light gray) or both
(dark gray). IFN-γ levels in CD4+ T cells (CD3+CD4+) 7 days postimmunization after in vitro restimulation with (A) aCD3 or (B) aCD3 or OMPS
were evaluated by FACS. Representative FACS plots and absolute numbers of intracellular IFN-γ in (A) SM1 CD4+ T cells and (B) CD4+ T cells are
shown; numbers in the quadrant represent quadrant frequency of the shown plot. (A and B, bottom right) Quantification of the IL-4 SFUs/5 ×
105 cells by ELISPOT. Data are shown as mean ± SD (n = 3 mice/group) and are representative of three independent experiments. *p  0.01, by 1
way ANOVA. (C) Representative FACS plots and quantification of the frequency of CD44+CD62L−CD4+ T cells at day 7. Data are shown as mean
± SD (n = 4 mice/group) and are representative of three independent experiments. *p  0.01, by 1 way ANOVA. (D) Bacteria burden in the spleen
of mice immunized with STm, FliC, or both STm/sFliC at day 7. Data are shown as mean ± SD (n = 3 mice/group) and are representative of three
independent experiments.
mice (anti-CD3 restimulation shown in Supporting Information
Fig. 2B and similar results were observed after restimulation with
OMPS).
To address if this diminution of the IFN-γ response impacted on
bacterial clearance at this time the bacterial burden between the
groups immunized with STm or STm/sFliC was assessed, which
showed no significant difference (Fig. 1D). Thus coimmunization
of sFliC and STm alters the IFN-γ response to STm and the IL-4
response to sFliC in both transgenic and endogenous CD4 T cells
without altering the capacity of mice to control the early stages
infection.
We then examined if these effects require the expression of
flagellin on the bacterium. To test this possibility, WT mice were
immunized as before alongside groups of mice infected with aflag-
ellate STm or aflagellate STm with sFliC. Flagellated and aflagel-
late STm induced similar numbers of IFN-γ+ T cells. Unexpectedly,
no reduction in the number of IFN-γ+ T cells was observed when
sFliC was coimmunized with aflagellated bacteria. This was not
due to a difference in the bacterial burden since these were similar
between the groups (Fig. 2). This was also not due to differences
in immune responses between these strains, since at early time
points no differences were observed in cDC and moDC numbers
and at day 7 equivalent numbers of activated T cells and similar Ab
responses were observed (Supporting Information Fig. 3). There-
fore, the capacity of sFliC to impair Th1 responses is dependent
upon parallel flagellin expression by the bacterium.
STm and sFliC coimmunization impairs T-bet+ T-cell
numbers in a TLR5-dependent manner
IFN-γ-production by T cells after STm infection is dependent upon
the transcription factor T-bet [6]. To assess at what stage during
Th1 differentiation, sFliC was modulating the IFN-γ production
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 2. Flagellin expression on the bacteria is required for IFN-γmod-
ulation. (A) WT mice were non-immunized or immunized with 5 ×
105 STm, STm/sFliC (20 μg), 5 × 105 Aflagellated STm or Aflagellated
STm/sFliC (20 μg). Intracellular IFN-γ in CD4+ T cells was evaluated
7 days postimmunization after in vitro restimulation with aCD3. (Left)
Absolute numbers of IFN-γ+ CD4+ T cells and (right) splenic bacteria
burden was measured by direct culture. Data are shown as mean ± SD
(n = 3 mice/group) and are representative of three independent exper-
iments. *p  0.01, by 1 way ANOVA.
we examined whether coimmunization of STm and sFliC simply
restricted the numbers of IFN-γ producing T cells, or whether
its impact was more profound, and impaired the induction of
T-bet in T cells. In comparison with the STm-immunized group,
the coimmunized mice had fewer IFN-γ+T-bet+ CD4 T cells and
fewer numbers of total T-bet+ CD4 T cells and even polyfunc-
tional IFN-γ+TNFα+ CD4 T cells. Notably, all IFN-γ+ T cells also
coexpressed T-bet, independently of whether the cells were res-
timulated with anti-CD3 or OMPS (Fig. 3A and data not shown).
We hypothesized that since TLR5 is the extracellular receptor for
sFliC, that this receptor may play a central role in this modulation
of Th1 differentiation. To test this we assessed Th1 cell numbers
in coimmunized WT and TLR5−/- mice. Numbers of T-bet+ T cells
were similar in WT and TLR5−/− mice given STm alone or sFliC
alone. In agreement with our hypothesis, the coimmunized WT
group had fewer IFN-γ+T-bet+ T cells and T-bet+ T cells whereas
in the TLR5−/− group there was no diminution in the propor-
tion or numbers of T cells of either phenotype (Fig. 3B). At this
day 7 time-point control of infection is independent of T cells
[4, 7], so to examine the impact of coimmunization on the later
T-cell response, bacterial burdens were examined at 3 weeks after
infection, when T-cell help is well established. Lower numbers of
T-bet+IFN-γ+ CD4+ T cells were detected at day 21 and coimmu-
nized mice had higher bacterial burdens at this time (Fig. 3C).
Therefore, sFliC coimmunization impairs the Th1 programme at
the level of T-bet induction and this occurs in a TLR5-dependent
manner. This effect persists and is reflected in a diminished rate
of clearance of bacteria from the spleen.
sFliC coimmunization does not modify the
T-independent early B-cell response to STm
Coimmunization with sFliC had a dramatic impact on the induc-
tion of Th1 cells, but it was also possible this may influence B-cell
responses too. In this model, the B-cell response to STm is atypical
since there is an extensive and rapid extrafollicular response that
occurs in the absence of germinal centers and the generation of
high-affinity antibody to the bacterium [20, 21]. The induction of
the B-cell response is T-independent but switching requires T cells.
Coimmunization with sFliC did not alter the induction of extrafol-
licular plasma cells and plasmablasts (Fig. 4A and B). Nor did it
alter numbers of T cells (PD1loCXCR5+) with a phenotype associ-
ated with extrafollicular switching after Salmonella infection and
that are diminished in the absence of the transcription factor BCL6
[22]. Nevertheless, there were fewer cells with features of germi-
nal center-associated T-follicular helper cells (Tfh, PD1+CXCR5+)
and germinal center B cells (Fas+GL7+) compared to mice that
only received sFliC (Fig. 4C, gating strategy shown in Supporting
Information Fig. 1B). We also addressed the antigen specificity
of the response by ELISPOT. IgM and IgG specific cells to OMPS
were detected with similar frequencies in mice immunized with
STm or coimmunized with STm/sFliC (Fig. 4D). Finally, we eval-
uated anti-OMPS Ab titers by ELISA 21 days postimmunization
and confirmed that there was no significant difference between
the groups immunized with STm or coimmunized with STm/sFliC
(Fig. 4E). Therefore, coimmunization with sFliC does not impair
the induction of B-cell responses to STm.
Coimmunization with sFliC impairs the early
activation of T cells
We then tried to pinpoint how early in the response sFliC
coimmunization had this effect. Assessment of early T-cell acti-
vation, by examining the expression of CD69 and CD62L (in
CD44−CD3+CD4+ T cells), showed that at 24 h postimmuniza-
tion there were 50% less CD69+CD62L+ CD4 T cells in mice that
received both antigens compared to mice that received STm only
(Fig. 5A). This suggested that although the total number of acti-
vated T cells eventually reached comparable levels, at the earliest
stages of the response there was some defect in T-cell priming,
possibly at the stage when DCs and T cells interact.
To examine whether sFliC altered the ability of DCs to acti-
vate antigen-specific T cells EYFP mice were immunized with STm
to generate a pool of STm-specific primed T cells. After 7 days
splenic T cells were enriched and 107 of these STm-experienced,
EYFP+ T cells were transferred into WT recipients to generate
chimeras. Twenty-four hours later these chimeras were immu-
nized with PBS, STm, sFliC, or both antigens and 24 h after-
wards, EYFP-activated splenic CD4 T cells were assessed by flow
cytometry. Mice that received both antigens had a significantly
lower proportion and number of EYFP-T cells expressing CD69
than mice that only received STm (Fig. 5B). Confocal microscopy
confirmed the flow cytometry results and showed there were more
CD69+ T cells in the T zone of STm-infected mice than in mice
that received other combinations of antigen (Fig. 5B lower panel).
Collectively, these results suggest that sFliC coimmunization alters
early T-cell activation in a manner that is likely to be dependent
upon the interaction of T cells with antigen-presenting cells.
C© 2015 The Authors. European Journal of Immunology published by
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Figure 3. sFliC influences the Th1 response to STm in a TLR5-
dependentmanner. (A)WTmicewere nonimmunized (white) or immu-
nized with 5 × 105 STm (black), 20 μg sFliC (light gray), or both (dark
gray). (Top) Representative FACS plots show intracellular IFN-γ and
T-bet expression on T cells (CD3+CD4+) 7 days postimmunization after
in vitro restimulation (αCD3 or OMPS). (Bottom) Absolute number of
IFN-γ+T-bet+ T cells and T-bet+ T cells per spleen were measured by
FACS. (B)WT (white) or TLR5−/− mice (black) were immunized as in A, T-
bet expression and intracellular IFN-γ after in vitro restimulation (αCD3
and OMPS) were evaluated by FACS, 7 days postinfection. (Top) Repre-
sentative plots show intracellular IFN-γ and T-bet expression on T cells
(CD3+CD4+). (Bottom) Absolute number of T-bet+IFN-γ+ T cells and of
T-bet+ T cells per spleen (C) WT mice were nonimmunized (white) or
immunized with STm (black), sFliC (light gray) or both (dark gray). (Top)
Representative FACS plots show intracellular IFN-γ and T-bet expres-
sion on T cells (CD3+CD4+) 21 days postimmunization after in vitro
Coimmunization with sFliC and STm alters the
activation of DCs and their cytokine profile
Since sFliC coimmunization altered priming and T-cell polariza-
tion to Th1 it suggested that sFliC may modulate DCs, as these are
the most efficient cell-type for priming na¨ıve T cells. The optimal
induction of IFN-γ in CD4 T cells after STm infection requires the
presence of cDC and moDC [18]. Each of these DC subsets has a
specific cytokine signature, so that at 24 h post-STm cDC are the
predominant source of IL-12 and moDC of TNFα. After infection
with attenuated STm in susceptible strains of mice, clearance of
bacteria is not dependent upon TNFα [23]. We hypothesized that
the defect in Th1 differentiation reflected a defective accumula-
tion of moDCs. To examine this, the kinetics of the DC response
after immunization with each antigen separately or together
was assessed (gating strategy shown in Supporting Information
Fig. 1C). As previously reported [18], at 24 h postimmunization
numbers of cDCs were similar in nonimmunized mice or those
immunized with STm or sFliC (Fig. 6A). There was an approx-
imate tenfold increase in moDCs after STm infection, which the
coimmunization with sFliC did not alter (Fig. 6B). This suggested
that although numbers of DCs were similar there may be some
defect in their function. Therefore the activation phenotype and
cytokine profile of cDCs and moDCs was examined. Analysis of
costimulatory molecules expression during the critical first 24 h
window after immunization showed that coimmunized mice had
significantly lower levels of CD86 and CD40 expression on cDC
compared to STm alone (Fig. 6A; CD80 expression showed a
similar profile as CD86, data not shown). Moreover, the kinetics
of cytokine production by the DC populations after STm was
substantially altered by the presence of sFliC. In cDCs at 2 h after
sFliC, or sFliC and STm together there was a pronounced spike in
IL-12 p40/p70 expression, which was higher than in cDCs from
STm-only infected animals. This then fell rapidly by 18 h the
proportion of cDCs expressing IL-12 p40/p70 was below that of
noninfected animals for all groups. Critically, numbers of cDCs
producing IL-12 p40/p70 at 18 and 24 h were significantly higher
in the STm-only infected than in the other two groups (Fig. 6A).
This suggested that DCs may have become exhausted, probably
due to the coordinated recognition of STm and sFliC. In contrast,
in mice only receiving STm a modest proportion of moDCs
expressed IL-12 p40/p70, but substantially more expressed
TNF-α (Fig. 5B), reflecting earlier findings [18]. Strikingly, in
coimmunized mice there was a significant reduction in the pro-
portion of moDCs expressing TNF-α (Fig. 6B).
Although there was a much higher frequency of DCs produc-
ing Th1-associated IL-12 p40/p70 at 2 h in sFliC and STm/sFliC
coimmunized mice, this is not likely to contribute to T-cell priming
by these DCs since there is no upregulation of the costimulatory
molecules CD40 and CD86 at this time, and in CD86-deficient

restimulation (αCD3). (Bottom) Absolute number of IFN-γ+Tbet+ T cells
and bacteria burden were measured by FACS. (A–C) Data are represen-
tative of three independent experiments. Data in graphs are shown as
mean ± SD (n = 4 mice/group) *p  0.01, by 1 way ANOVA.
C© 2015 The Authors. European Journal of Immunology published by
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Figure 4. sFliC coimmunization with STm
does not affect the T-independent B cell
response to STm. WT mice were nonim-
munized (white) or immunized with 5 ×
105 STm (black), 20 μg sFliC (light gray) or
both (dark gray) for 7 days. (A) Immuno-
histological assessment of the splenic GCs
(PNA, blue; IgD, brown) and plasma cells
(CD138, blue; IgD, brown). Representative
photomicrographs of three independent
experiments are shown. T; T zone, B; B
zone, scale bar: 200 μm. Quantification of
(B) CD138+ B cells and of (C) Tfh cells
(PD1+CXCR5+), PD1lowCXCR5+ T cells, and
GC B cells (Fas+GL7+) in the spleen was
made by FACS. (Gating strategies shown in
Supporting Information Fig. 1B). (D) IgM and
IgG response to STm OMPS 7 days postim-
munization measured by ELISPOT. (E) Anti-
OMPS serum IgG and IgG2a titers were eval-
uated 21 days postimmunization by ELISA.
(B–E) Data are shown as mean ± SD (n = 4
mice/group) and are representative of three
independent experiments. *p  0.01, by
1 way ANOVA.
mice T-cell activation after STm or both antigens is absent (data
not shown). That DCs have not primed T cells at this point was sup-
ported by the vast majority of SM1 T cells not expressing CD69at
2 h postimmunization, (Fig. 6C), when there is the spike in IL-12
p40/p70 production (Fig. 6A) in the sFliC and the STm/sFliC-
treated groups. It is possible that there may be differences in
the kinetics of activation, or other factors affecting T-cell prim-
ing, that are not detected using these methods. In contrast, by
24 h the changes were dramatic with most of the T-cell popula-
tion expressing CD69and poised to begin dividing (Fig. 6C). Using
this approach we also examined IL-12 p40/p70 production in situ
24 h postimmunization, and showed that within the T zones of
mice that only received STm some DCs were in close contact with
SM1-CFSE cells and producing IL-12 p40/p70, confirming our flow
cytometry data. This was not observed in the T zones of mice that
received STm and sFliC (Fig. 6D). Therefore, co-immunization
with sFliC does not change the number of DCs recruited into the
response, but modulates the activation of DC subsets and their
expression of Th1-associated cytokines at the time of priming.
To further study the effects observed by these antigens on
DC maturation we examined the in vitro response of splenic cDCs
purified from nonimmunized mice. Splenic DCs stimulated in vitro
with STm, sFliC, or STm/sFliC for 1 h and cultured overnight
showed no difference in the upregulation of CD86 and CD40
between STm and STm/sFliC. This may indicate that the observed
defect in the upregulation of costimulatory molecules in the group
treated with STm/sFliC was due to the interaction of different sub-
sets activated in vivo or that moDCs, which are excluded from the
in vitro system, contribute to these findings (Supporting Informa-
tion Fig. 4). To determine whether the differences observed in DC
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 5. Coimmunization of sFliC and STm leads to a defective early
T-cell activation in comparison with STm immunization alone. (A) WT
mice were nonimmunized (white) or immunized with 5 × 105 STm
(black), 20 μg sFliC (light gray), or both (light gray). Early T-cell activa-
tion was evaluated 24 h postimmunization. (Top) Representative FACS
plots show T-cell (CD3+CD4+CD44−) activation by the expression of
CD69 and CD62L; numbers represent frequency within the quadrant.
(Bottom) Quantification of CD69+CD62L+ T cells at that time point.
(B) Early T-cell activation was evaluated in a chimeric system using
STm antigen-experienced T cells. EYFPmicewere STm infected (5× 105
SL3261) for 7 days. T cells were isolated and MACS-enriched to transfer
107 EYFP T cells into WT mice, 24 h posttransfer mice were nonimmu-
nized or immunized with 5 × 105 STm (black), 20 μg sFliC (light gray), or
both (dark gray), activationwas evaluated on EYFP+ T cells. (Top) Repre-
sentative plots show the expression of CD69 on EYFP+TCRαβ+CD4+ cells
(middle) frequency and the absolute number of CD69+EYFP+ T cells at
function in the coimmunized mice were due to TLR5 stimulation
we firstly examined CD86 expression in WT and TLR5−/− mice
24 h postimmunization. TLR5−/− mice coimmunized with STm
and sFliC had a similar expression of CD86 to the STm-only
infected group, indicating that TLR5 was responsible for the
observed differences in WT coimmunized mice (Fig. 7A). As
expected we did not observe any upregulation of CD86 in TLR5−/−
mice immunized with sFliC alone.
Lastly, to confirm that the diminished T-cell activation and
polarization was due to defects in DC function, we performed
ex vivo experiments using DCs from mice immunized with STm,
sFliC, or both antigens to condition the DCs in vivo. DCs were
FACS sorted, with a purity >97% (Supporting Information Fig.
1D). Sorted DCs were mixed with CFSE-labeled CD4+CD62Llo
T cells sorted from mice infected with STm 7 days previously (at
a ratio of 1 DC:20 T cells), again to increase the pool of antigen-
specific T cells to STm. To ensure all DCs had equivalent access
to antigen, purified OMPS were added to the culture mix and the
proportion of dividing T cells assessed 4 days later. DCs isolated
from coimmunized mice were less capable than DC from STm-
immunized mice at driving T-cell proliferation ex vivo (Fig. 7B).
Therefore, coimmunization with sFliC and STm directly modulates
DCs and their capacity to drive effective T-cell activation.
Discussion
While Th1 responses are essential for the control of many intra-
cellular infections, they can also have undesirable effects, such as
contributing to the immune-mediated pathology often observed
as infections are cleared [2]. Therefore, understanding the factors
that help limit the expansion of Th1 responses could be of signif-
icant therapeutic benefit. This study shows that the Th1 response
to flagellated, but not aflagellate, STm can be selectively mod-
erated after coimmunization with sFliC through a modulation of
DC maturation and cytokine production. Despite the requirement
for bacteria to be flagellated for the effects of sFliC coimmuniza-
tion to be apparent, our data suggest it is not only impacting
flagellin-specific T cells. This is because the effects of sFliC coim-
munization were observed after restimulation with both anti-CD3
and purified OMPS and FliC-specific T cells make only a small pro-
portion of responding T cells in the early, endogenous response.
Therefore, this offers potential as an intervention in reducing Th1-
mediated immunopathology during infection by TLR5-stimulating
bacteria. The reason why sFliC only affects the response to flag-
ellated bacteria and not to aflagellated bacteria is unclear. A key
point is that although the coimmunization only has effects in the

24 h postimmunization. (Bottom) Composite confocal representative
images of spleens fromWTmice 24 h postimmunization. Images show
CD69 (blue), CD3 (red), and IgM (white). (Top) Low magnification (scale
bar: 200μm) and (bottom) highermagnification of the boxed areas (scale
bar: 20 μm) are shown. (A and B) Data are shown as mean ± SD (n = 3-4
mice/group) and are representative of three independent experiments.
*p  0.01, by 1 way ANOVA.
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Figure 6. cDCs phenotype and cytokine profile are altered when sFliC is coimmunized with STm in comparison with the single immuniza-
tions. (A and B) WT mice were immunized with 5 × 105 STm (black), 20 μg sFliC (light gray), or both (dark gray). Absolute number of (A) cDCs
(Lin(B220/CD3/NK1.1)−CD64− MHC-II+CD11c+) and (B)moDCs (Lin(B220/CD3/NK1.1)−CD64+Ly6C+) 24 h postimmunizationwere calculated by FACS
analysis. CD86 and CD40 expression 2, 18, and 24 h postimmunization was measured by FACS. Percentage of IL-12 p40/p70 and TNFα 2, 18, and
24 h postimmunization was measured by FACS. Data are shown as mean ± SD (n = 3 mice/group) and are representative of three indepen-
dent experiments. *p  0.01; **p  0.001, by 1 way ANOVA. (C) WT mice were transferred i.v. with 10 × 106 CFSE labeled SM1 splenocytes, 24
h posttransfer recipients were nonimmunized or immunized as in (A and B). Representative contour plots show SM1 T-cell (CFSE+CD3+CD4+)
activation defined as CD69 expression 2 and 24 h postimmunization. Numbers indicated frequency within the quadrant. (D) Composite confocal
representative images of recipients splenic T zones 24 h postimmunization, showing CFSE (green), CD11c (blue), and IL-12 p40/p70 (red). (Scale
bar: 25 μm). Arrows indicate close interaction between CFSE cells and CD11c+IL-12 p40/p70+ cells. Images are representative of three independent
experiments.
presence of flagellated STm, the impact is on FliC-specific and non-
specific T cells. This supports the concept that the initial influence
is on DCs and their interaction with T cells and not necessarily
on T cells. Since the effects of these interactions are still apparent
at day 21 on both the clearance of infection and the numbers of
IFN-γ+ T cells, it demonstrates that the consequence of this coex-
posure to flagellated bacteria and sFliC has a lasting and dramatic
effect on the host response. The context of antigen encounter in
vivo is likely to be critical for this since in vitro experiments did
not recapitulate the modifying effects seen in vivo. This suggests
that DCs are likely to be influenced by their environment as well
as their capacity to acquire antigen directly. While T-bet express-
ing T-cell numbers were dramatically reduced after coimmuniza-
tion with sFliC, numbers of PD11owCXCR5+ T cells, associated
with extrafollicular responses [22] were not and this reflected
the normal early IgM and IgG antibody response to STm. In con-
trast cells with a phenotype shared with germinal-center Tfh cells
(PD1+CXCR5+) were not induced, despite being elevated when
mice were immunized with sFliC alone. Collectively, this indicates
that sFliC coimmunization can affect the development of the Th1
response to a broad repertoire of antigens within the bacterium
yet is specific in only targeting flagellated bacteria. We focused
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Figure 7. DCs conditioning in vivo mediates the T-cell response.
(A) DCs (Lin−(B220/CD3/NK1.1)MHC-II+CD11c+) phenotype analysis of
WT (white) and TLR5−/− (black) mice 24 h postimmunization with 5 ×
105 STm (black), 20 μg sFliC (light gray), or both (dark gray). (Left) Rep-
resentative histograms and (right) MFI CD86 values postimmunization
are shown. (B) DCs were cell sorted from mice immunized as in (A) to
use as APC (see detailed plots in Supporting Information Fig. 1C) 24 h
postimmunization. T cells were cell sorted from 7 days STm-infected
(5 × 105 SL3261) mice and CFSE labelled. Cells were cocultured in a 1:20
(DC:T) proportion for 4 days and T-cell division was analyzed by CFSE
dilution. (Left) Representative histograms and percentage of dividing
T cells are shown. (A and B) Data are shown as mean ± SD (n = 3
mice/group) and are representative of three independent experiments.
**p  0.001 by 1 way ANOVA.
on the response to STm in the spleen as it is a site where we
have previously shown that after i.p. immunization with STm or
sFliC, T-cell priming occurs with similar kinetics. While systemic
infection with STm, when given i.p. has rapid effects on home-
ostasis in sites such as the bone marrow [24] and thymus [25],
we do not see T-cell priming in sites such as the mesenteric LN
or the popliteal lymph node until after the first day of immuniza-
tion (unpublished observations). In contrast, sFliC administered
i.p. can drive wide-ranging responses in a number of secondary
lymphoid tissues concurrently [26].
We initially used sFliC in these studies because it had pre-
viously been demonstrated to induce Th2 features to itself and
coadministered antigens when administered as a soluble antigen.
The capacity of Th2 antigens to alter Th1 responses have been
demonstrated previously [27]. Nevertheless, the effects described
in this study do not appear to be related to the capacity of sFliC to
induce Th2 features since IL-4 production was absent after coim-
munization. Furthermore, we have not observed these effects after
coimmunization with other Th2 antigens. For instance after coin-
fection with STm and the Th2-inducing helminth N. brasiliensis
there is no abrogation in Th1 cell numbers or IFN-γ production
[10] nor after coimmunization with alum-precipitated OVA and
STm expressing OVA. Collectively, this indicates that the abil-
ity to moderate Th1 responses is probably unrelated to the Th2-
inducing properties of sFliC. The mechanism underlying the mod-
ulating properties of sFliC turned out to be surprising. In vivo and
ex vivo experiments showed that DCs from coimmunized mice
were poorer at activating T cells and inducing T-cell prolifera-
tion than DCs from mice that only received STm. This indicates
that after coimmunization sFliC acts on DCs. We observed two
major effects on DCs after coimmunization, which were altered
expression of the co-stimulatory molecules CD40 and CD86 and
an altered cytokine profile. The importance of effective induction
of costimulatory molecules has been addressed extensively before
and studies have shown that in the absence of optimal expression
of costimulatory molecules by DCs then the functional quality of
the T-cell response is impaired [28, 29]. Coupled with lower cos-
timulatory molecule expression, there were fewer DCs expressing
the Th1-associated cytokines IL-12 p40/p70 or TNFα by 18 h after
immunization. This 12–18 h period is critical since this is when
we have found that DCs prime T cells after systemic STm infection
and so altered DC function is likely to lead to lower T-bet induc-
tion [4, 6]. Nevertheless, there may be events occurring before
18 h, associated with T-cell priming that may not be detected by
our technical approach. Potentially the C15.6 clone used to detect
IL-12 p40/p70 could also detect IL-23 being produced from cDCs
and future experiments will confirm whether cDCs produce only
IL-12 p40/p70 or if they also produce IL-23.
How can the presence of sFliC have such effects? It is unlikely to
be through simply inducing a tolerizing environment since these
effects were observed in IL-10-deficient mice after coimmuniza-
tion, and there was not a significant change in FoxP3+ T-cell
numbers and furthermore flagellin can act as an adjuvant to a
number of coimmunized antigens such as OVA [16, 30]. Data
from multiple studies suggest that at the early time-points exam-
ined here TLR5 expression is more critical on DCs and myeloid
cells [31–33] than T cells. This is supported here since sFliC coim-
munization in TLR5−/− mice did not alter DC activation and there
was no diminution in Th1 priming compared to WT mice. So, how
would coimmunization affect the DC populations in vivo? One
element to consider is that the response to several TLRs at once
differs to when engaging just one. The potential synergy of TLR
stimulation has been addressed previously, mainly by combining
two ligands. However, after STm and sFliC there are more than
two TLRs that can be ligated. In some systems it has been reported
that the stimulation of TLR4 and TLR5 actually leads to an inhibi-
tion of IL-12 p40/p70 and TNF-α production [34]. Other reports
suggest that synergistic ligation of TLRs can enhance activation
of transcription factors such as NF-κB, but that the outcome can
be variable depending on the time after stimulation and the par-
ticular TLR combination studied [35] and many of such studies
have examined the response in vitro [34–36]. A key implication of
our results is that triggering DC responses through the additional
exposure to sFliC can alter DCs in an unexpected and nonsyner-
gistic manner. In this case the complex signals transduced after
multiple TLR stimulation results in a lower level of DC activation
and an impaired capacity to prime for Th1 cells. Therefore the
interplay between TLRs is more nuanced than always enhancing
a response. In our system, cells probably receive two tone sig-
naling through TLR5, one via bacterial expression and one via
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encountering sFliC [37, 38]. This means that it is likely that sFliC
is only modulating the function of DCs that already contain bac-
teria. Additionally, previous data suggest that there is a division
of labor between DCs for inducing Th1 cells and Tfh cells in this
model of STm-infection with moDCs being necessary for optimal
priming of IFN-γ-secreting T cells but moDCs are dispensable for
the generation of IgG2a-switched extrafollicular plasma cells [18].
An implication of these findings is the capacity of STm and
S. Typhi to modulate the expression of flagellin throughout the
infection. It has been shown that Salmonella downregulates flag-
ellin expression when it disseminates and the infection becomes
systemic (spleen and liver) [39–43]. Nevertheless, studies have
shown that although flagellin production is reduced after systemic
infection it is not necessarily switched off and can have additional
activities as a monomer produced by intracellular bacteria [44].
This suggests the activities described here could be relevant in
mucosal and systemic sites and help modulate the response in
target organs such as the liver, particularly as we have shown
that parenteral administration of sFliC can impact the intestinal
mucosa [26].
In summary, sFliC exposure can alter the tone of the adaptive
response to flagellated bacteria. DCs are of central importance for
this and therefore priming for Th1 responses requires a balancing
of signals through engaging multiple TLRs [36, 45]. This adds to
the growing list of immunomodulatory activities that sFliC has on
the host and provides additional focus for its translational poten-
tial in humans [46, 47].
Material and methods
Mice
Specific pathogen-free 6–8 week C57BL/6 mice were purchased
fromHarlan Sprague–Dawley. SM1 [46], TCRβδ−/−, TLR5−/−, and
EYFP mice were maintained in-house. All animal procedures were
carried out in strict accordance with local ethical approval from
the University of Birmingham and the UK Home Office license
(Project license 30/2850) as covered by the Animals (Scientific
procedures) Act 1986.
Antigen preparation and immunizations
sFliC was generated as previously described [19]. Mice were
immunized i.p. with 20 μg recombinant sFliC. STm SL3261 AroA−
[48] was cultured in Luria Bertani broth and harvested at mid-log
phase for immunization. Mice were infected i.p. with 5 × 105
live STm in PBS. Aflagellated SL3261 (SW564) has a deletion of
the fljB and fliC genes by replacement with an aminoglycoside
phosphotransferase gene and chloramphenicol acetyltransferase
cassette. In some experiments, the bacterial burden in tissues was
evaluated by direct culturing.
Cell preparation and FACS
Single cell suspensions from spleens and LNs were generated by
mechanical disruption or collagenase IV (Worthington Biochem-
ical) digestion (400 U/mL; 25 min; 37°C) when evaluating DCs.
Cells were processed for FACS analysis accordingly with stan-
dard procedures. Antibodies are listed in Supporting Information
Table 1.
For intracellular IFN-γ and T-bet staining, total splenocytes
were plated at 6 × 106 cells/mL with 1 μg/mL of anti-CD28 Ab
and restimulated in a precoated well with anti-CD3 (10 μg/mL),
OMPS (5 μg/mL), or culture medium for 6 h at 37°C, with BFA
(10 μg/mL) for the last 2 h. Intracellular staining was performed
by using the transcription factor staining buffer accordingly to
manufacturer instructions (eBiociences).
When required, DCs were negatively enriched using MACS
beads and LS columns (Miltenyi Biotec; CD19, CD5, and DX5
beads; purity 85%). Enriched DCs were plated at 3 × 106
cells/mL and cultured overnight with GolgiStopTM (8 μg/mL).
Intracellular staining was performed using Cytofix-Cytoperm (BD
Biosciences). For in vitro cultures enriched DCs were incubated in
antibiotic-free medium with 5 × 103 STm, 0.2 μg sFliC, or both
for 1 h at 37°C. Cultures were then washed and resuspended in
medium with antibiotics to culture overnight.
ELISPOT analysis
For cytokine secretion the ELISPOT was perform as described
before [18]. In brief, IL-4 ELISPOT was performed using a mouse
IL-4 ELISPOT kit (eBioscience, Hatfield, UK). A total of 4 × 105
splenocytes were plated per well in medium alone or in presence
of sFliC (5 μg/mL) and anti-CD28 antibody (1 μg/mL) and cul-
tured for 48 h at 37°C. B cell ELISPOTwas performed as previously
described [26]. In brief, ELISPOT Plates (MultiScreen; Millipore)
were precoated with 5 μg/mL of OMPS and 4 × 105 splenocytes
were plated per well. Cells were cultured for 6 h at 37°C. Spots
were counted using the AID ELISPOT Reader System and AID
software version 3.5 (Autoimmune Diagnostika).
Generation of T-cell chimeras and assessment of
T-cell priming
SM1 chimeras were generated as previously described [4] by
transfer of 107 CFSE-labeled SM1 splenocytes i.v. into WT mice
24 h before immunization and the T-cell-specific response was
evaluated at the indicated time-points postimmunization. In some
cases EYFP mice were infected i.p. with 5 × 105 SL3261 to expand
the antigen specific T-cell pool. Spleens and LNs were harvested 7
days postinfection and T cells were positively enriched by MACS
using CD5 beads (Miltenyi Biotech). Subsequently, 107 enriched
T cells were transferred i.v. into WT mice 24 h before immuniza-
tion.
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Immunohistochemisty and confocal microscopy
Immunohistology was performed as described previously [19].
Cryosections were incubated with primary unlabeled Abs for
45 min at RT before addition of either HRP-conjugated or
biotin-conjugated secondary antibodies. Signal was detected using
diaminobenzidine for HRP activity and naphthol AS-MX phos-
phate with Fast Blue salt and levamisole for alkaline phosphatase
activity.
Confocal was performed as previously described [18]. For
detection of cytokines in situ, sections were fixed with 4%
paraformaldehyde for 20 min. Confocal images were acquired
using a Zeiss LSM510 laser scanning confocal microscope with a
Zeiss AxioVert 100 M. Signals obtained from lasers were scanned
separately and stored in four nonoverlapping channels as pixel
digital arrays of 2048 × 2048 (10X objective) or 1024 × 1024
(63X objective).
OMPS-specific ELISA
ELISA plates were coated with 5 μg/mL of OMPS (2 h at 4°C)
and blocked with 1% BSA overnight at 4°C. Serum was diluted
1:100 in PBS/0.05% Tween and diluted stepwise; plates were
incubated for 1 h at 37°C. Bound Abs were detected using alka-
line phosphatase conjugated, goat anti-mouse IgG, and IgG2a abs
(Southern Biotech). Reaction was developed with Sigma-Fast p-
nitrophenylphosphate (Sigma Aldrich). Relative reciprocal titers
were calculated by measuring the dilution at which the serum
reached a defined OD405.
In vitro coculture of DCs and T cells
WT mice were immunized i.p. with STm (5 × 105), sFliC (20 μg)
or both for 24 h. Cell suspensions prepared as described above.
Cells were preenriched by depleting CD19+, DX5+, and CD5+ cells
by MACS beads before staining with CD11c, MHC-II, and CD64
to FACS sort APCs. cDC (CD11chiMHC-IIhighCD64−) and moDC
(CD11c+MHC-II+CD64+) were sorted from STm and STm/sFliC
immunized mice. In N.I. and sFliC-immunized mice only cDCs
were purified. Purity was 97% in all cases. T cells were isolated
from 7 days STm-infected WT mice infected. T cells were cell
sorted (CD3+CD4+CD62Llow) and CFSE labeled. DC were added
in a 1:20 proportion (APC:T) and cultured for 4 days. Cells were
harvested and analyzed by FACS to assess T-cell division by CFSE
dilution.
Statistics
Statistics were calculated using the nonparametric 1 way ANOVA,
Mann–Whitney sum of ranks test using Prism software with
p values of  0.05 accepted as significant.
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